Drugs that contain Setmelanotide Acetate

1. Drug name - IMCIVREE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9458195 RHYTHM Melanocortin receptor ligands
Oct, 2027

(5 years from now)

US8039435 RHYTHM Melanocortin receptor ligands
Oct, 2027

(5 years from now)

CN101676298A RHYTHM Melanocortin Receptor Ligand
Apr, 2014

(8 years ago)

CN101257916B RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

CN103755786A RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

CN101257916A RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

CN103755786B RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

IN200904039P2 RHYTHM A Melanocortin-4 Selective Receptor Agonist Compound
Jul, 2026

(3 years from now)

IN290770B RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

IN290823B RHYTHM A Melanocortin-4 Selective Receptor Agonist Compound
Jul, 2026

(3 years from now)

IN200800208P2 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2286825A3 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2548568A2 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2548568B1 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2286825B1 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2286825A2 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP3354273A1 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2548568A3 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP3354273B1 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2236151B1 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

EP2236151A1 RHYTHM Melanocortin Receptor Ligands
Jul, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11129869 RHYTHM Pharmaceutical compositions Jul, 2034

(11 years from now)

Treatment: NA

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
EQ 10MG/ML BASE (EQ 10MG/ML BASE) SOLUTION;SUBCUTANEOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.